Transcainide
Code | Size | Price |
---|
TAR-T26287-1mg | 1mg | £286.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26287-5mg | 5mg | £603.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26287-10mg | 10mg | £828.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26287-25mg | 25mg | £1,187.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26287-50mg | 50mg | £1,581.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26287-100mg | 100mg | £2,127.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Transcainide is an antiarrhythmic agent with potential clinical application.
CAS:
88296-62-2
Formula:
C22H35N3O2
Molecular Weight:
373.541
Pathway:
Membrane transporter/Ion channel
Purity:
0.98
SMILES:
CN(C)C1(CCN(CC1)[C@@H]1CCCC[C@H]1O)C(=O)Nc1c(C)cccc1C
Target:
Sodium Channel
References
1. Carmeliet E, Janssen PA, Heykants J, Niemegeers CJ, Remeysen P, Van De Water A, Van Gerven W, Wauquier A, Xhonneux R. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide. Arch Int Pharmacodyn Ther. 1987 Jun;287(2):272-90. PubMed PMID: 3632145.
2. Bennett PB, Stroobandt R, Kesteloot H, Hondeghem LM. Sodium channel block by a potent, new antiarrhythmic agent, transcainide, in guinea pig ventricular myocytes. J Cardiovasc Pharmacol. 1987 Jun;9(6):661-7. PubMed PMID: 2442531.
3. Yang X, Yu T, Kesteloot H. Clinical and electrophysiologic studies of R61748 (transcainide): a new class Ic antiarrhythmic drug. Acta Cardiol. 1992;47(1):43-56. PubMed PMID: 1378674.
4. Hill RJ, Thakore E, Taouis M, Duff HJ, Sheldon RS. Transcainide: biochemical evidence for state-dependent interaction with the class I antiarrhythmic drug receptor. Eur J Pharmacol. 1991 Oct 2;203(1):51-8. PubMed PMID: 1665791.